Estimations des analystes de Wall Street pour Jaguar Health, Inc. (JAGX): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-12 | $-40.95 | ||
| 2026-08-19 | $-15.70 | $-52.15 | +69.9% |
| 2026-05-20 | $-13.60 | $-71.40 | +81.0% |
| 2026-04-07 | $-3.14 | $-1.49 | -110.6% |
| 2025-11-12 | $-2.20 | $-1.78 | -23.6% |
| 2025-08-14 | $-3.59 | $-2.50 | -43.8% |
| 2025-05-15 | $-5.84 | $-3.79 | -54.3% |
| 2025-03-31 | $-5.15 | $-6.47 | +20.4% |
Ratios de valorisation
| Prix / Valeur comptable | 0.03 |
| EV / EBITDA | -0.25 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $141523 | $4.4M | $4.4M | $5.8M | $9.4M | $4.3M | $12.0M | $9.8M | $11.7M | $11.5M |
| Coût des Ventes | $51966 | $880405 | $2.8M | $3.8M | $3.3M | $2.3M | $2.0M | $2.0M | $2.0M | $3.8M |
| Marge Brute | $89557 | $3.5M | $1.7M | $2.0M | $6.1M | $2.0M | $9.9M | $7.7M | $9.7M | $7.7M |
| R&D | $7.2M | $4.3M | $5.2M | $5.8M | $6.4M | $15.1M | $17.6M | $18.6M | $16.5M | $25.0M |
| Frais Généraux | $6.5M | $14.3M | $22.1M | $20.4M | $21.0M | $26.0M | $26.7M | $23.0M | $24.0M | $26.0M |
| Charges Opérationnelles | $13.7M | $18.6M | $27.3M | $30.9M | $32.8M | $42.7M | $44.4M | $42.0M | $40.6M | $52.8M |
| Résultat Opérationnel | -$13.6M | -$34.2M | -$30.8M | -$28.9M | -$26.6M | -$40.7M | -$34.4M | -$34.3M | -$30.8M | -$45.1M |
| EBITDA | -$13.7M | -$11.1M | -$27.8M | -$30.9M | -$28.7M | -$42.4M | -$33.4M | -$32.8M | -$36.7M | -$51.7M |
| Charges d'Intérêt | $985549 | $1.2M | $2.6M | $5.7M | $2.8M | $8.4M | $12.7M | $6.4M | $231000 | -$67000 |
| Résultat Avant Impôts | -$14.7M | -$35.1M | -$32.1M | -$38.5M | -$33.8M | -$52.6M | -$48.4M | -$41.9M | -$39.3M | -$54.0M |
| Impôts | 0 | -$13.2M | 0 | $10000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Net | -$14.7M | -$22.0M | -$32.1M | -$38.5M | -$33.8M | -$52.6M | -$47.5M | -$41.3M | -$38.5M | -$53.4M |
| BPA | $-16744218756.00 | $-6325593752.00 | $-1810550318.00 | $-106403456.00 | $-11814153.00 | $-4631759.00 | $-1899528.00 | $-93992.00 | $-4574.07 | $-803.95 |
| BPA Dilué | $-16744218756.00 | $-6325593752.00 | $-1810550318.00 | $-106403456.00 | $-11814153.00 | $-4631759.00 | $-1899528.00 | $-93992.00 | $-4574.07 | $-803.95 |
| Actions en Circulation (Diluées) | 0 | 0 | 0 | 0 | $3 | $11 | $25 | $439 | $8415 | $66640 |
Prix
| Prix | $0.23 |
| Capitalisation | $0M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: BDRX · CANF · CLDI · CNSP · GNPX · GRI · INM
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de JAGX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions